Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;46(7):1067-1076.
doi: 10.1111/jog.14309. Epub 2020 May 19.

Immune tolerance at the maternal-placental interface in healthy pregnancy and pre-eclampsia

Jorge Valencia-Ortega  1 , Renata Saucedo  1 , María I Peña-Cano  2 , Marcelino Hernández-Valencia  1 , José G Cruz-Durán  3
Affiliations
Review

Immune tolerance at the maternal-placental interface in healthy pregnancy and pre-eclampsia

Jorge Valencia-Ortega et al. J Obstet Gynaecol Res. 2020 Jul.

Abstract

Aim: The objective of this review is to describe the immunological mechanisms which facilitate maternal tolerance at the maternal-placental interface, and to discuss how these mechanisms are disrupted in pre-eclampsia.

Methods: A literature review was performed based on the analysis of papers available on PubMed. The most important and relevant studies regarding the immunological mechanisms which facilitate maternal tolerance in healthy pregnancy and pre-eclampsia are presented in this article.

Results: The maternal-placental interface is the site where the immune tolerance begins and develops. Within the innate immunity, natural killer cells, macrophages and dendritic cells play a pivotal role in tolerance through regulation of inflammation. On the other hand, within the adaptive immunity, the correct increase of regulatory T cells is crucial for ensuring immune tolerance toward placental cells. Disturbances in maternal tolerance can lead to the appearance of pregnancy complications such as pre-eclampsia, which has a considerable impact on perinatal morbidity and mortality.

Conclusion: Our partial knowledge of immunological mechanisms involved in tolerance at the maternal-placental interface indicates that pre-eclampsia is characterized by alterations of this maternal immune tolerance, which could represent the origin of the disease.

Keywords: immune tolerance; placenta; pre-eclampsia; pregnancy; trophoblast.

PubMed Disclaimer

References

    1. Medawar PB. Some immunological and endocrinological problems raised by evolution of viviparity invertebrates. Symp Soc Exp Biol 1953; 7: 320-328.
    1. Deshmukh H, Way SS. Immunological basis for recurrent fetal loss and pregnancy complications. Annu Rev Pathol 2019; 14: 185-210.
    1. The American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 202: Gestational hypertension and pre-eclampsia. Obstet Gynecol 2019; 133: e1-e25.
    1. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: A systematic review. Lancet 2006; 367: 1066-1074.
    1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137.

LinkOut - more resources